Fever may be the only clinical symptom at the onset of infection in neutropenic cancer
patients undergoing myelosuppressive chemotherapy. A prompt and evidence-based …

abstract Bloodstream infections (BSI) are among the most frequent complications in
neutropenic cancer patients and, if caused by Gram-negative rods, are associated with high …

Infectious diseases are important causes of morbidity and mortality in patients with cancer.
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prevention and …

This document updates and expands the initial Infectious Diseases Society of America
(IDSA) Fever and Neutropenia Guideline that was published in 1997 and first updated in …

Purpose To provide guidelines on antimicrobial prophylaxis for adult neutropenic oncology
outpatients and on selection and treatment as outpatients of those with fever and …

PURPOSE: Febrile neutropenia remains a potentially life-threatening complication of
anticancer chemotherapy, but some patients are at low risk for serious medical …

This article, prepared by the Infectious Diseases Society of America (IDSA) Fever and
Neutropenia Guidelines Panel, updates guidelines established a decade ago by the …

Background The prophylactic use of fluoroquinolones in patients with cancer and
neutropenia is controversial and is not a recommended intervention. Methods We randomly …

Patients with cancer are at increased risk for developing infectious complications during the
course of their disease and treatment. The following sections of the NCCN Clinical Practice …

Risk stratification of febrile neutropenic patients can have important implications in terms of
management. The first prospectively validated risk scoring system was developed in 1992. A …